Meet Us at Antibody Engineering & Therapeutics 2018

ImmunoPrecise will be attending Antibody Engineering & Therapeutics 2018, the annual meeting of The Antibody Society, where you can find the latest science, technologies and partners in antibody engineering, immunobiology, and next generation biomarkers.

Meet Us at Booth 107

Meet with our global team at Booth #107 to find out more about our comprehensive collection of antibody discovery platforms and how we can accelerate next generation antibodies to commercial success. This event features plenty of opportunities for networking and collaborating with leading pharma, biotech, and academia from North America, Asia, and Europe.

Schedule a Meeting with us to learn about how we can further your therapeutic antibody discovery.

Location:
Manchester Grand Hyatt San Diego
San Diego, CA

Date:
December 9-13, 2018

Booth #107

ImmunoPrecise Attendees:

Meet Us at the 10th Annual PEGS Summit Europe

ImmunoPrecise, ModiQuest Research, and U-Protein Express will be attending the 10th annual PEGS Summit Europe. PEGS (Protein & Antibody Engineering Summit) is the largest European event for all aspects of protein and antibody engineering, offering keynote speakers, seminars, dedicated networking, and short courses.

Meet Us at Booth 615

Meet with our team at booth #615 to learn more about our full service cycle of therapeutic antibody discovery. Dr. Jos Raats, Dr. Roland Romijn, and Nienke Smits and will be attending from ModiQuest Research and U-Protein ExpressContact us to set up a meeting.

Interested in meeting attendees with similar interests and goals? Check out PEGS Europe’s new 1-on-1 networking system.

Location: Lisbon Congress Center
Lisbon, Portugal

Date: November 12th-16th, 2018

Booth: #615

European Antibody Congress 2018

ImmunoPrecise at European Antibody Congress 2018

ImmunoPrecise is excited to announce that we will be a part of the European Antibody Congress within the Festival of Biologics in Basel, Switzerland from October 29th to 31st.

The European Antibody Congress is a multi-streamed conference and technology exhibition that brings together over 1000 attendees, including representatives from big pharma, biotechs, academia and technology innovators. Offering opportunities for networking with industry peers, conference segments featuring enlightening talks from industry leaders, and an exhibition showcasing the latest technical innovations in the field, the event is the perfect place to feel connected and inspired.

ImmunoPrecise’s CSO, Dr. Deanna Dryhurst will be in attendance, along with ModiQuest’s Head of Contract Research, Dr. Debby Kruijsen who will also be a feature speaker in the on-floor seminar’s Drug Discovery Technology panel discussion. The panel will address modern therapeutics antibody drug discovery technologies and how our platforms can face the challenges of drug discovery. The panel will take place on Day 1, October 29th, at 12:45-13:25.

Location

Congress Centre Basel
Messepl. 21, 4058 Basel, Switzerland

Booth #42

Date

October 29th to 31st, 2018.

View the conference agenda here.

US West Coast Antibody Engineering Xchange 2018

ImmunoPrecise at US West Coast Antibody Engineering Xchange 2018

ImmunoPrecise is excited to announce that we will be attending hubXchange’s US West Coast Antibody Engineering Xchange in San Diego on September 26th, 2018.

HubXchange specializes in delivering high-level content, intelligence and connections to the global Life Sciences community by hosting outstanding business Xchanges. These meetings are a series of highly-interactive roundtable discussions bringing together executives and senior academics over the course of one day. This ‘sharing-learning‘ platform is a powerful tool helping to address and find solutions to real-world industry challenges. HubXchange’s US West Coast Antibody Engineering Xchange 2018 will bring together executives from the pharma and biotech sectors, as well academia.

ImmunoPrecise will be presenting the keynote industry talk and facilitating two roundtable discussions focused on antibody discovery- providing insight and offering solutions on how we can face challenges in the antibody engineering industry.

Roundtable Discussion Topics

Maximizing Target-Specific Antibody Sequence Diversity in Discovery Campaigns

Facilitated by Dr. Barry Duplantis – Client Relations & Project Manager

Improving Efficiency in Identifying Lead Candidates

Facilitated by Dr. Andra Li – Director of Molecular Laboratory Services

Location

Handlery Hotel, 950 Hotel Circle Drive,
San Diego

Date

September 26th, 2018.

Meet with ImmunoPrecise at the 16th Annual Discovery on Target

ImmunoPrecise is excited to be exhibiting at this year’s Discovery on Target conference from September 25th to 28th in Boston, MA. Visit booth #213 at the Sheraton Boston, and discover how ImmunoPrecise can further your therapeutic antibody development. With over 1,300 drug discovery professionals in attendance, representing over 20 different countries, DOT 2018 is the perfect opportunity to learn, connect, and share information in this rapidly expanding and constantly developing field.

Click here to schedule a meeting with one of our delegates from ImmunoPrecise or Modiquest Research!

Meet with one of our representatives to discuss our featured services

Including:

  • B-cell Select
  • Human Monoclonals
  • Advanced Hybridoma Development
  • Phage Display
  • Rabbit Monoclonals
  • Rapid Prime Immunization
  • Genetic Immunization
  • Antibody Characterization and Optimization
  • Antibody Engineering
  • Protein & Antibody Expression

About ImmunoPrecise

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery. We deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

ImmunoPrecise operates from state-of-the-art laboratory facilities located at the Vancouver Island Technology Park in Victoria, British Columbia, in collaboration with its wholly-owned subsidiary operations at U-Protein Express B.V., in the Life Science Incubator, Utrecht, and ModiQuest Research, Oss, both in the Netherlands.

Set up a meeting to learn more!

About Discovery on Target

The 16th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.

 

Antibody Engineering & Therapeutics Europe June 5th-7th, 2018 – Meet with ImmunoPrecise & ModiQuest Research

ImmunoPrecise & ModiQuest Reseach B.V. will be exhibiting at the upcoming Antibody Engineering & Therapeutics Europe in Amsterdam! Come visit us at Booth #10

Featured Services

  • B cell Selection Technologies
  • Advanced Hybridoma Development
  • Antibody Characterization & Optimization
  • Phage Display
  • Cryostorage
  • Preferred OmniAb® Service Provider
  • Antibody Humanization
  • Custom Naïve & Immune Human Libraries
  • Protein Expression
  • Proprietary Immunization Strategies

 

Schedule a Meeting!

About ImmunoPrecise:

ImmunoPrecise Antibodies Ltd. is a full-service, antibody discovery CRO focused on the next generation of antibody discovery. We aim to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with highest probability of succeeding to clinical trials.

IPA is a single source provider of services for the complete antibody discovery value chain. We offer the most comprehensive collection of antibody discovery platforms in the industry, combined with state of the art lead candidate optimization and characterization. This allows us to assist clients from the moment they identify a therapeutic target to the preparation of applying for investigation review of the clinical product.

AET Europe Information:

Brought to you by the same organizers of Antibody Engineering & Therapeutics US, in conjunction with The Antibody Society; AET Europe brings together the latest science, technologies, and partners needed to accelerate  next generation antibodies to commercial success.

AET Europe will be held at the Hilton Amsterdam:
Apollolaan 138, 1077 BG
Amsterdam, Netherlands

 

BIO International Convention June 4th-7th, 2018 – Meet with ImmunoPrecise

ImmunoPrecise will be at the upcoming BIO International Convention in Boston and looks forward to meeting with you.

Featured Services

  • B cell Selection Technologies
  • Advanced Hybridoma Development
  • Preferred OmniAb® Service Provider
  • Phage Display
  • Antibody Characterization & Optimization
  • Human Monoclonals
  • Custom Naïve & Immune Human Libraries
  • Protein Expression
  • Cryostorage

 

Begin your BIO One-on-One Partnering!

About ImmunoPrecise:

ImmunoPrecise Antibodies Ltd. (IPA) is a full-service, antibody discovery CRO focused on the next generation of antibody discovery. We aim to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

IPA is a single source provider of services for the complete antibody discovery value chain. We offer the most comprehensive collection of antibody discovery platforms in the industry, combined with state of the art lead candidate optimization and characterization. This allows us to assist clients from the moment they identify a therapeutic target to the preparation of applying for investigation review of the clinical product.

BIO 2018 Information:

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotech centers and related organizations across the United States and over 30 other nations. BIO One-on-One Partnering™ is the most efficient way to do business in the biotech and pharma industry without traveling all over the world. #BIO2018

BIO 2018 will be held at the Boston Convention & Exhibition Center: 415 Summer St, Boston, MA 02210

For more information, please contact us.

 

Meet ImmunoPrecise at the Protein & Antibody Engineering Summit (PEGS) in Boston

 

ImmunoPrecise will be exhibiting at the upcoming PEGS Summit conference, April 30th to May 4th in Boston.

Meet the Team

Come say hello to our team at booth 618.  Here are the IPA team members that will be attending.

  • Teri Otto – VP, Marketing and Sales Support
  • Deanna Dryhurst – Chief Scientific Officer
  • Andra Li – Director of Molecular Services
  • David Kroeger – Senior SCcientist, Director of Hybridoma Services

 

 

About ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies is a CRO/CMO dedicated to the development and production of high quality custom antibodies. Our dedication to advancing antibody development has resulted in cutting-edge immunological innovations. With over 25 years of experience in the custom antibody business, IPA provides high customer satisfaction through a customized professional approach. Our clients include: scientists in the biotech and pharmaceutical sector, academic researchers and government sector.

Featured Services

  • Rabbit Monoclonals
  • Hybridoma Development
  • Human Monoclonals
  • Protein Expression
  • Cryostorage
  • Antibody Expression

See All IPA Services

 

PEGS Boston Information

PEGS Boston features nearly 400 presentations by world renowned leaders from pharma, academia, and government showcasing case studies, cutting edge data, insight and perspective. Conference programs include a broad spectrum of topics including protein and antibody engineering, cancer immunotherapy, oncology, and emerging therapeutics.

The convention will take place at Seaport World Trade Center located at 1 Seaport Ln, Boston, MA 02210, USA

JP Morgan Healthcare Conference

ImmunoPrecise Antibodies Attending J.P. Morgan Healthcare Conference Week January 8-11, 2018

ImmunoPrecise will be attending the J.P. Morgan 36th Annual Healthcare Conference running from January 8-11, 2018 in San Francisco, California.

Thirty-five years ago, J.P. Morgan launched Wall Street’s premier investor conference focused exclusively on companies defining the healthcare industry. The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry. In 2018, J.P. Morgan expects more than 400 companies, both public and private, to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting.

For more information on the event visit https://www.jpmorgan.com/country/US/EN/jpmorgan/investbk/conferences/healthcare

Visit booth #219 at Antibody Engineering & Therapeutics 2017

Meet ImmunoPrecise at Antibody Engineering & Therapeutics 2017

If you will be attending the Antibody Engineering & Therapeutics show, make sure to stop by booth #219!  This is a great opportunity to meet with our scientists, discuss your research, and start a conversation on how ImmunoPrecise would go about building a custom project tailored to your specific needs.

Antibody Engineering & Therapeutics 2017
December 11-15, 2017
Manchester Grand Hyatt San Diego, CA

Event Websitehttps://lifesciences.knect365.com/antibody-engineering-therapeutics